Biofil Chemicals and Pharmaceuticals Limited (NSE:BIOFILCHEM)

Market Cap	757.06M
Revenue (ttm)	334.02M
Net Income (ttm)	5.58M
Shares Out	n/a
EPS (ttm)	0.34
PE Ratio	135.72
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,040
Average Volume	58,331
Open	46.67
Previous Close	46.91
Day's Range	45.33 - 47.00
52-Week Range	40.40 - 91.87
Beta	1.63
RSI	40.78
Earnings Date	May 30, 2025

About NSE:BIOFILCHEM

Biofil Chemicals and Pharmaceuticals Limited manufactures and trades in pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and plastic drippers and caps for packing applications. It also provides job work service for manufacturing pharmaceutical drugs. Biofil ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1985
• Employees: 26
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BIOFILCHEM

Financial Performance

In 2024, NSE:BIOFILCHEM's revenue was 334.02 million, a decrease of -17.34% compared to the previous year's 404.09 million. Earnings were 5.58 million, a decrease of -21.35%.